Mr. Vishal Jajodia
CMD: Swati Spentose Pvt Ltd
Celebrating a Decade of Innovation: Swati Spentose Pvt Ltd – “Innovation Made in India – For the World”
As we step into the 10th year of our incredible journey, we reflect on the milestones that have shaped us. What started with GIBS 2016 and the historic ESSIC 2016—bringing the European Society to Asia for the first time—has now evolved into a global movement in the field of IC/BPS. The journey has not only been a personal dream come true for Swati Spentose Pvt Ltd but also a path of empowerment for both clinicians and patients around the world.
Looking back, the past 10 years have seen significant progress and a strong commitment to addressing the needs of underserved patients worldwide. GIBS 2025—Celebrating a DECADE—will mark this exciting milestone, and we couldn’t be prouder of how far we’ve come.
Throughout this journey, we’ve provided a continuous platform of learning and collaboration. From webinars to conferences and workshops, we’ve shared knowledge, fostered partnerships, and made strides in improving patient care. This ongoing commitment to education and collaboration has helped clinicians and patients alike by providing much-needed solutions and support.
Our success is not just measured by milestones but by the real impact we’ve made on patient lives by making this crucial drug at affordable rates have already made a difference for patients who once had no viable options.
Our most exciting endeavor yet is going to be the approval of a generic Elmiron (Pentosan) at the US-FDA, a feat that no other pharmaceutical company has been able to achieve in the past 2 decade, since the patent expired in 2010.
This decade-long journey has been filled with challenges, triumphs, and progress, and I am immensely proud to be part of this evolution. The future is bright, and as we continue to build on this foundation, the GIBS 2025 conference will be a momentous occasion to reflect on all we’ve achieved while looking ahead to even greater opportunities for growth and collaboration.
The next phase of our journey includes expanding our reach even further—bringing together gynecologists, uro-gynecologists, and other specialists from around the world to collaborate and deliver innovative solutions for IC/BPS. Our aim is not just to treat but to create a larger global movement that stands as a beacon of hope and care for underserved patients worldwide.
As we move forward, we continue to be driven by our vision: “Innovation Made in India – For the World.” Join us in this next exciting chapter, as we celebrate our achievements, reflect on our past, and look forward to the future.